Evidence map›Paper›PMID 34465901›Full record

ArticleOncogene2021

PHF10 subunit of PBAF complex mediates transcriptional activation by MYC.

N V Soshnikova, E V Tatarskiy, V V Tatarskiy, N S Klimenko, A A Shtil, M A Nikiforov, S G Georgieva

Open access · greenAbstract read
In one paragraph

Article in Oncogene, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. SMARCD1 and Its Functional Relevance in SWI/SNF and Cancer.International journal of molecular sciences · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

N V SoshnikovaDepartment of Eukaryotic Transcription Factors, Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia. nsoshnikova@genebiology.ru.ORCID http://orcid.org/0000-0001-9260-3068
E V TatarskiyDepartment of Eukaryotic Transcription Factors, Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
V V TatarskiyLaboratory of Molecular Oncobiology, Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
N S KlimenkoCenter for Precision Genome Editing and Genetic Technologies for Biomedicine, Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
A A ShtilLaboratory of Molecular Oncobiology, Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
M A NikiforovDepartment of Cancer Biology, Wake Forest University, Winston-Salem, NC, USA.ORCID http://orcid.org/0000-0001-7868-0518
S G GeorgievaDepartment of Eukaryotic Transcription Factors, Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia. sofia.georgieva2021@gmail.com.
Institute of Gene Biology · RUEngelhardt Institute of Molecular Biology · RUWake Forest University · US

Funding

KLF9-TXNRD2 axis in melanoma progression and metastasisR01CA190533 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI NIKIFOROV, MIKHAIL · 2015 to 2019
$2.0M
GMPS-GMPR Axis Melanoma Progression and TherapyR01CA224434 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI NIKIFOROV, MIKHAIL · 2018 to 2022
$2.0M
Regulation and Function of Very Long Chain Fatty Acid Biosynthesis in Multiple MyelomaR01CA264984 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI NIKIFOROV, MIKHAIL · 2021 to 2025
$1.9M
Inhibition of MYC interactions with chromatin-remodeling factors as a novel anti-melanoma strategyR21CA220096 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI NIKIFOROV, MIKHAIL · 2017 to 2019
$402k
NCI NIH HHS R01 CA190533NCI NIH HHS R01 CA224434NCI NIH HHS R01 CA264984NCI NIH HHS R21 CA220096
6 · The paper itself

Abstract

The PBAF complex, a member of SWI/SNF family of chromatin remodelers, plays an essential role in transcriptional regulation. We revealed a disease progression associated elevation of PHF10 subunit of PBAF in clinical melanoma samples. In melanoma cell lines, PHF10 interacts with MYC and facilitates the recruitment of PBAF complex to target gene promoters, therefore, augmenting MYC transcriptional activation of genes involved in the cell cycle progression. Depletion of either PHF10 or MYC induced G1 accumulation and a senescence-like phenotype. Our data identify PHF10 as a pro-oncogenic mechanism and an essential novel link between chromatin remodeling and MYC-dependent gene transcription.

Indexed as

Gene Regulatory NetworksCell Line, TumorCellular SenescenceChromatin Assembly and DisassemblyDisease ProgressionG1 Phase Cell Cycle CheckpointsGene Expression ProfilingGene Expression Regulation, NeoplasticHomeodomain ProteinsHumansMelanomaNeoplasm MetastasisNeoplasm ProteinsPromoter Regions, GeneticProto-Oncogene Proteins c-mycSequence Analysis, RNAHomeodomain ProteinsMYC protein, humanNeoplasm ProteinsPHF10 protein, humanProto-Oncogene Proteins c-myc

Identifiers

PMID34465901
PMCPMC8863208
OpenAlexW3198245208

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.